Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome

BACKGROUND: Schistosomiasis is a neglected tropical disease burdening millions of people. One drug, praziquantel, is currently used for treatment and control. Clinically relevant drug resistance has not yet been described, but there is considerable heterogeneity in treatment outcomes, ranging from c...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneeberger, Pierre H. H., Coulibaly, Jean T., Panic, Gordana, Daubenberger, Claudia, Gueuning, Morgan, Frey, Jürg E., Keiser, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848565/
https://www.ncbi.nlm.nih.gov/pubmed/29530088
http://dx.doi.org/10.1186/s13071-018-2739-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848565/
https://www.ncbi.nlm.nih.gov/pubmed/29530088
http://dx.doi.org/10.1186/s13071-018-2739-2

Ejemplares similares